Search Results - "GARCIA PUIG, Juan"

Uric acid and oxidative stress: Relative impact on cardiovascular risk by Strazzullo, Pasquale, Puig, Juan Garcia

“…Abstract Post-hoc analyses of the GREACE and the LIFE trials have renewed the interest in elevated serum uric acid (SUA) as a factor contributing to…”
Get full text

Macrocytic anemia in Lesch–Nyhan disease and its variants by Cakmakli, Hasan F., Torres, Rosa J., Menendez, Araceli, Yalcin-Cakmakli, Gul, Porter, Christopher C., Puig, Juan Garcia, Jinnah, H. A.

“…Purpose Lesch–Nyhan disease is an inherited metabolic disorder characterized by overproduction of uric acid and neurobehavioral abnormalities. The purpose of…”
Get full text

A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease by Khasnavis, Tanya, Torres, Rosa J., Sommerfeld, Barbara, Puig, Juan Garcia, Chipkin, Richard, Jinnah, H.A.

“…Lesch-Nyhan disease (LND) is a genetic disorder that has characteristic metabolic, neurologic, and behavioral features. There are multiple behavioral problems…”
Get full text

Macrocytic anemia in Lesch–Nyhan disease and its variants by Cakmakli, Hasan F., Torres, Rosa J., Menendez, Araceli, Yalcin-Cakmakli, Gul, Porter, Christopher C., Puig, Juan Garcia, Jinnah, H.A.

Get full text

Knowledge of stroke warning symptoms and intended action in response to stroke in Spain: a nationwide population-based study by Lundelin, Krista, Graciani, Auxiliadora, García-Puig, Juan, Guallar-Castillón, Pilar, Taboada, José M, Rodríguez-Artalejo, Fernando, Banegas, José R

“…Worldwide thrombolysis rates remain suboptimal. Ambulance transfer is associated with greater use of this time-dependent treatment. Information on public…”
Get more information

Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR study by Marre, Michel, Puig, Juan Garcia, Kokot, Franciszek, Fernandez, Margarita, Jermendy, György, Opie, Lionel, Moyseev, Valentin, Scheen, André, Ionescu-Tirgoviste, Constantin, Saldanha, M Helena, Halabe, Aaron, Williams, Bryan, Mion, Decio, Ruiz, Maximino, Hermansen, Kjeld, Tuomilehto, Jaakko, Finizola, Bartolomé, Gallois, Yves, Amouyel, Philippe, Ollivier, Jean-Pierre, Asmar, Roland

“…OBJECTIVESTo test whether microalbuminuria in patients with type 2 diabetes and hypertension is primarily dependent on the severity of hypertension, and to…”
Get full text

Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54‐Week, Open‐Label Study by Murray, Alexander V., Koenig, Wolfgang, Garcia‐Puig, Juan, Patel, Samir, PhD, Alkaz Uddin, Zhang, Jack

“…J Clin Hypertens (Greenwich). 2012; 14:821–827. ©2012 Wiley Periodicals, Inc. Combination antihypertensive therapies are recommended to attain blood pressure…”
Get full text

Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants by Sampat, Radhika, Fu, Rong, Larovere, Laura E, Torres, Rosa J, Ceballos-Picot, Irene, Fischbach, Michel, de Kremer, Raquel, Schretlen, David J, Puig, Juan Garcia, Jinnah, H. A

“…Lesch-Nyhan disease is a neurogenetic disorder caused by mutation of the HPRT1 gene on the X chromosome. There is significant variation in the clinical…”
Get full text

Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study by Dahlöf, Björn, Gosse, Philippe, Guéret, Pascal, Dubourg, Olivier, de Simone, Giovanni, Schmieder, Roland, Karpov, Yuri, García-Puig, Juan, Matos, Lajos, De Leeuw, Peter W, Degaute, Jean-Paul, Magometschnigg, Dieter

“…OBJECTIVEFew data are available comparing the effects of monotherapy and combination therapy on target organ damage. The PICXEL study compared the efficacy of…”
Get full text

Physician perception of blood pressure control and treatment behavior in high-risk hypertensive patients: a cross-sectional study by Banegas, José R, Lundelin, Krista, de la Figuera, Mariano, de la Cruz, Juan J, Graciani, Auxiliadora, Rodríguez-Artalejo, Fernando, Puig, Juan García

“…We examined physician perception of blood pressure control and treatment behavior in patients with previous cardiovascular disease and uncontrolled…”
Get full text

Clinical profile of eprosartan by GARCIA PUIG, Juan, MARTINEZ LOPEZ, Maria A, SANCHO BUESO, Teresa, BERNARDINO, José I, TORRES JIMENEZ, Rosa

“…Angiotensin II (AII) receptor blockers offer an alternative means of blocking the renin-angiotensin-aldosterone system (RAAS) to angiotensin converting enzyme…”
Get full text

High prevalence of masked uncontrolled hypertension in people with treated hypertension by Banegas, José R, Ruilope, Luis M, de la Sierra, Alejandro, de la Cruz, Juan J, Gorostidi, Manuel, Segura, Julián, Martell, Nieves, García-Puig, Juan, Deanfield, John, Williams, Bryan

“…There are limited data on the quality of treated blood pressure (BP) control during normal daily life, and in particular, the prevalence of 'masked…”
Get full text

Hyperuricemia, gout and the metabolic syndrome by Puig, Juan García, Martínez, María Angeles

“…PURPOSE OF REVIEWThe metabolic syndrome is defined by the clustering of a number of cardiovascular risk factors and entails an increased risk for…”
Get full text

ABPM in patients with heart failure: a long way to go by García Puig, Juan, Banegas, José R.

Get full text

Comprehensive cardiovascular risk management--what does it mean in practice? by Erhardt, Leif, Moller, Robert, Puig, Juan García

“…The continued movement away from the treatment of individual cardiovascular (CV) risk factors to managing overall and lifetime CV risk is likely to have a…”
Get full text

Clinic Versus Daytime Ambulatory Blood Pressure Difference in Hypertensive Patients: The Impact of Age and Clinic Blood Pressure by Banegas, José R, Ruilope, Luis M, de la Sierra, Alejandro, Vinyoles, Ernest, Gorostidi, Manuel, de la Cruz, Juan J, Segura, Julián, Oliveras, Anna, Martell, Nieves, García-Puig, Juan, Williams, Bryan

“…Clinic blood pressure (BP) is usually higher than daytime ambulatory BP in hypertensive patients, but some recent studies have challenged this view, suggesting…”
Get full text

Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure Goals: Post Hoc Analysis of the Spanish Ambulatory Blood Pressure Monitoring Registry by Ruilope, Luis M, Ruiz-Hurtado, Gema, Barderas, María G, de la Cruz, Juan J, Lucia, Alejandro, de la Sierra, Alejandro, Gorostidi, Manuel, Vinyoles, Ernest, Segura, Julián, Solís, Jorge, Arribas, Fernando, García-Puig, Juan, Tamargo, Juan, O’Brien, Eoin, Volpe, Massimo, Whelton, Paul K, Williams, Bryan, Banegas, José R

“…United States and European guidelines have recommended new treatment goals for office blood pressure (BP). We examined 9784 hypertensives of the Spanish…”
Get full text

Atherosclerosis as a potential pitfall in the diagnosis of giant cell arteritis by De Miguel, Eugenio, Beltran, Luis M, Monjo, Irene, Deodati, Francesco, Schmidt, Wolfgang A, Garcia-Puig, Juan

“…Abstract Objectives To explore whether the increase in the intima-media thickness (IMT) in arteriosclerotic disease correlates with the increase in the IMT in…”
Get full text

Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure Goals by Ruilope, Luis M, Ruiz-Hurtado, Gema, Barderas, María G, de la Cruz, Juan J, Lucia, Alejandro, de la Sierra, Alejandro, Gorostidi, Manuel, Vinyoles, Ernest, Segura, Julián, Solís, Jorge, Arribas, Fernando, García-Puig, Juan, Tamargo, Juan, O'Brien, Eoin, Volpe, Massimo, Whelton, Paul K, Williams, Bryan, Banegas, José R

“…United States and European guidelines have recommended new treatment goals for office blood pressure (BP). We examined 9784 hypertensives of the Spanish…”
Get full text

Familial juvenile hyperuricaemic nephropathy (FJHN): linkage analysis in 15 families, physical and transcriptional characterisation of the FJHN critical region on chromosome 16p11.2 and the analysis of seven candidate genes by STIBURKOVA, Blanka, MAJEWSKI, Jacek, MATTHIJS, Gert, FRYNS, Jean-Pierre, TORRES, Rosa, GARCIA PUIG, Juan, OTT, Jurg, KMOCH, Stanislav, HODANOVA, Katerina, ONDROVA, Lenka, JERAHBKOVA, Markéta, ZIKANOVA, Marie, VYLET'AL, Petr, SEBESTA, Ivan, MARINAKI, Anthony, SIMMONDS, Anne

“…Familial juvenile hyperuricaemic nephropathy (FJHN) is an autosomal dominant renal disease characterised by juvenile onset of hyperuricaemia, gouty arthritis,…”
Get full text